The effect of Ginkgo biloba extract (EGb 761) on bleomycin (BLM)-induced acute lung injury was studied in rats. The responsiveness of isolated pulmonary arterial rings to 5-hydroxytryptamine (5-HT) as well as the levels of some relevant biochemical markers in the lung tissue were taken as evidence for the acute lung injury. BLM was given intraperitoneally at a dose of 15 mg/kg/day for five consecutive days. It was found that BLM treatment attenuated the vasoconstrictor effect of 5-HT on the isolated pulmonary arteries. In lung tissues BLM also elevated the level of lipid peroxides and enhanced the activity of glutathione peroxidase. On the other hand, the level of glutathione and the activity of alkaline phosphatase were reduced. Body weight, lung weight and tissue glutathione-S-transferase activity were, however, not altered. Oral administration of EGb 761 at a dose of 100 mg/kg/day for five consecutive days did not alter any of the chosen biochemical parameters in the lung tissue except for a slight reduction in alkaline phosphatase activity. However, treatment with EGb 761 reduced the responsiveness of the pulmonary artery to 5-HT. Administration of EGb 761 (100 mg/kg/day; po) two hours prior to BLM (15 mg/kg/day; ip), for five consecutive days blunted the occurrence of further reduction in the vasoconstrictor response of the pulmonary artery to 5-HT. Furthermore, EGb 761 tended to normalize BLM-induced alterations in the measured biochemical markers in the lung tissue. The apparent modulatory influence of EGb 761 on BLM-induced acute lung injury stems, at least in part, from its beneficial free radical scavenging properties that provide the extract with antioxidant activity.
OrtizL.A., LaskyJ., HamiltonR.F.Jr., HolianA., HoyleG.W., BanksW., PeschonJ.J., BrodyA.R., LungarellaG., FriedmanM.: Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.Exp Lung Res, 24: 721–743, 1998.
6.
KhalilN., WhitmanC., ZuoL., DanielpourD., GreenbergA.: Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat.J Clin Invest, 92: 1812–1818, 1993.
7.
O'NeilC.A., GiriS.N.: Biochemical mechanisms for the attenuation of bleomycin-induced lung fibrosis by treatment with niacin in hamsters: the role of NAD and ATP.Exp Lung Res, 20: 41–56, 1994.
8.
EvansT.W., McAnultyR.J., RogersD.F., ChungK.F., BarnesP.J., LaurentG.J.: Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN52021 and platelet depletion.Environ Health Perspect, 85: 65–69, 1990.
9.
GiriS.N., SharmaA.K., HydeD.M., WildJ.S.: Amelioration of bleomycin-induced lung fibrosis by treatment with the platelet activating factor receptor antagonist WEB 2086 in hamsters.Exp Lung Res, 21: 287–307, 1995.
10.
ParizadaB., WerberM.M., NimrodA.: Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis.Free Radic Res Commun, 15: 297–301, 1991.
11.
HabibM.P., LackeyD.L., LantzR.C., SobonyaR.E., GradR., EarnestD.L., BloomJ.W.: Vitamin A pretreatment and bleomycin-induced rat lung injury.Res Commun Chem Pathol Pharmacol, 81: 199–208, 1993.
12.
KaramH., Hurbain-KosmathI., HoussetB.: Antioxidant activity in alveolar epithelial type 2 cells of rats during the development of bleomycin injury.Cell Biol Toxicol, 14: 13–22, 1998.
AkisuM., KultursayN., CokerI., HuseyinovA.: Platelet activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain.Biol Neonate, 74: 439–444, 1998.
FukayaH., KannoH.: Experimental studies of the protective effect of Ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats.Nippon Jibiinkoka Gakkai Kaiho, 102: 907–917, 1999.
22.
El-KashefH.A.: Hyperglycaemia increased the responsiveness of isolated rabbit's pulmonary arterial rings to serotonin.Pharmacology, 53: 151–159, 1996.
23.
OhkawaH., OhishiN., YagiK.: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.Anal Biochem, 95: 351–358, 1979.
HabigW.H., PabstM.J., JakobyW.B.: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.J Biol Chem, 249: 7130–7139, 1974.
26.
PagliaD.E., ValentineW.N.: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.J Lab Clin Med, 70: 158–169, 1967.
27.
BelfieldA., GoldbergD.M.: Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine.Enzyme, 12: 561–573, 1971.
28.
CoursinD.P., CihlaH.P.: Non-lethal hyperoxic potentiation of lung disease in the rat following subcutaneous administration of bleomycin.Toxicology, 16: 45–55, 1988.
29.
HofmanW.F., EhrhartI.C.: Vascular reactivity and permeability to serotonin in cyclooxygenase inhibited dog lung.Am J Physiol, 255: H1096–1105, 1988.
30.
El-KashefH.A., HofmanW.F., EhrhartI.C.: Effect of lipoxygenase inhibitor on vasoconstriction in dog lung.Am J Physiol, 257: H1977–1982, 1990.
31.
HofmanW.F., JacksonW.F., El-KashefH.A., EhrhartI.C.: Modulation of vascular reactivity to serotonin in the dog lung.J Appl Physiol, 71: 217–222, 1991.
32.
SjogrenA., EdvinssonL.: Vasomotor changes in isolated coronary arteries from diabetic rats.Acta Physiol Scand, 134: 429–436, 1988.
33.
BlockE.R.: Factors affecting the fluidity of the endothelial cell plasma membrane. In: Vascular endothelium: receptors and transduction mechanisms, CatravasJ.D., GillisC Norman, RyanU.S. (eds), 29–42, Plenum Press, New York, 1989.
34.
OrrF.W., AdamsonI.Y., WarnerD., LeroyerV., WernerL., ShaughnessyS., YoungL.: The effects of oxygen radical-mediated pulmonary endothelial damage on cancer metastasis.Mol Cell Biochem, 84: 189–198, 1988.
35.
CirinoG.: Multiple controls of inflammation. Extracellular and intracellular phospholipase A2, inducible and constitutive cyclooxygenase, and inducible nitric oxide synthase.Biochem Pharmacol, 55: 105–111, 1998.
36.
CrossC.E., WarrenD., GerrietsJ.E., WilsonD.W., HalliwellB., LastJ.A.: Deferoxamine injection does not affect bleomycin-induced lung fibrosis in rats.J Lab Clin Med, 106: 433–438, 1985.
37.
MuraokaY., TakitaT., UmezawaH.: Bleomycin and peplomycin. In: Cancer chemotherapy, PinedoH.M., ChabnerB.A. (Eds.), vol. 8, pp. 65–72, Elsevier, New York, 1986.
38.
GiriS.N., ChenZ.L., YounkerW.R., SchiedtM.J.: Effects of intratracheal administration of bleomycin on GSH-shuttle enzymes, catalase, lipid peroxidation and collagen content in the lungs of hamsters.Toxicol Appl Pharmacol, 71: 132–141, 1983.
39.
GiriS.N., MisraH.P., ChandlerD.B., ChenZ.L.: Increases in lung propylhydroxylase and superoxide dismutase activities during bleomycin-induced lung fibrosis in hamsters.Exp Mol Pathol, 39: 317–326, 1983.
40.
FildermanA.E., GenoveseL.A., LazoJ.S.: Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice.Biochem Pharmacol, 37: 1111–1116, 1988.
41.
HalliwellB.: Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?Lancet, 344: 721–724, 1994.
42.
El-KhatibA.S.: Biologically active free radicals and their scavengers: a review.Saud Pharm J, 5: 79–89, 1997.
43.
CheesemanK.H., SlaterT.F.: An introduction to free radical biochemistry.Br Med Bull, 49: 481–493, 1993.
44.
ChandlerD.B., BartonJ.C., BriggsD.D.3rd, ButlerT.W., KennedyJ.I., GrizzleW.E., FulmerJ.D.: Effect of iron deficiency on bleomycin-induced lung fibrosis in the hamster.Am Rev Respir Dis, 137: 85–89, 1988.
45.
VenkatesanN.: Pulmonary protective effects of curcumin against paraquat toxicity.Life Sci, 66: 21–28, 2000.
SuntresZ.E., ShekP.N.: Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing alpha-tocopherol and glutathione.Biochem Pharmacol, 52: 1515–1520, 1996.
48.
DuG., WilletK., Mouithys-MickaladA., Sluse-GoffartC.M., Droy-LefaixM.T., SluseF.E.: EGb 761 protects liver mitochondria against injury induced by in vitro anoxia/reoxygenation.Free Radic Biol Med, 27: 596–604, 1999.
49.
AghaA.M., El-FattahA.A., El-ZuhairH.H., Al-RikabiA.C.: Chemopreventive effect of Ginkgo biloba extract against benzo(a)pyrene-induced forestomach carcinogenesis in mice: amelioration of doxorubicin cardiotoxicity.J Exp Clin Cancer Res, 20: 39–50, 2001.
